UNSPSC 51122301: Cardioplegic solution

This classification denotes solutions which, on administration, temporarily arrest cardiac activity, solutions typically used in heart surgery.

UNSPSC 51122301 Cardioplegic solution, a Commodity code, encompasses emergency and critical-care medications supplied to municipal fire rescue services, state health agencies, and multistate purchasing cooperatives—including epinephrine, labetalol, adenosine, diltiazem, and related advanced life support drugs. State and local governments buy these products primarily for emergency medical services (EMS) operations, pharmacy benefit programs, and healthcare facility distribution networks. Issuing bodies span municipal fire departments (City of Tampa), state health commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). Vendors must maintain cGMP and Drug Supply Chain Security Act (DSCSA) compliance, submit Safety Data Sheets meeting OSHA Hazard Communication Standards, and guarantee minimum nine-month to one-year shelf life from acceptance. Contracts typically impose firm pricing inclusive of freight, electronic data interchange (EDI) capability, and inventory management obligations including pickup and replacement of expired stock before expiration.

Recent activity shows geographically distributed solicitation across Florida, Texas, and Minnesota. The City of Tampa issued ITB 26P00188 for Advanced Life Support Medications due April 8, 2026, requesting 370 units of labetalol, 1,810 units of epinephrine, 330 units of adenosine, and 1,020 units of diltiazem with a $40,000 estimated contract value and a 5 percent small local business enterprise (SLBE) bid discount available. The Texas Health and Human Services Commission issued RFI HHS0017013 in March 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling future formal solicitation for direct-contracting pharmaceutical supply. The Minnesota Department of Administration's Office of State Procurement issued RFP S1070000015802 through MMCAP due March 26, 2026, soliciting generic multi-source pharmaceuticals and OTC products for distribution across Minnesota, Oregon, and participating jurisdictions, requiring vendor pricing submission through authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) with a two-year contract term and 3 percent administrative fee assessed on all purchases.